EMCDDA news

The online space has become increasingly relevant in identifying trends in illicit drug supply and demand. With increased internet activity globally, drug-related social interactions and purchases have also partially moved online. Against this backdrop, web surveys have become a key element in a range of tools used to monitor the drug phenomenon. In a new set of papers released today, the EMCDDA explores the future of web surveys in drug data collection and their ‘great promise’ in filling research gaps in the drugs field. 29.06.2022 

Vice-Prime Minister and Minister of Health of Luxembourg Paulette Lenert visits the EMCDDA today during an official visit to Portugal. The Minister will meet EMCDDA Director Alexis Goosdeel and Chair of the EMCDDA Management Board Franz Pietsch. The Director will present the evolution of the agency’s work and its ongoing activities. 20.06.2022 

Good morning, First of all, I would like to express our warm thanks to Commissioner Ylva Johansson for her permanent support and also to Dr Franz Pietsch, the Chair of the EMCDDA Management Board. Are drugs different today? What can we do about this? 20.06.2022 

2021 was a year of transformation for the EMCDDA as the agency reached new milestones in its journey towards a customer-centric, data-driven and digitally-enabled organisation. These developments are described in the latest General Report of Activities released today. The annual report presents the implementation of the agency’s work programme activities in 2021, by providing an overview of key achievements and governance. 15.06.2022 

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary. Operated by the EMCDDA, in close cooperation with Europol and partners (1), it was the first regional early-warning mechanism set up to monitor and respond to uncontrolled new drugs. Today, ahead of the anniversary on 16 June, the Early Warning System network holds its annual meeting in Lisbon. 07.06.2022